Based on previous studies done in mice, researchers observed that GLP-1 agonists/DPP-4 inhibitors work to reduce inflammation in the gut, so they proposed that the same mechanism may occur in humans (5, 6)
This mechanism is well understood and documented
Ozempic, or Semaglutide GLP-1, is primarily utilized in managing type 2 diabetes but has shown promising results in aiding weight loss when combined with a balanced diet and regular exercise
Your provider has confirmed the dose is appropriate This one matters most
However, specific timing may depend on individual preferences and health goals
Up until now, most weight loss medications: Had massive side effects Produced poor weight loss results Effects wore off over time These new injectable drugs provide much more significant results and as long as the person keeps taking them, it appears that the results are long-lasting